A

Arecor Therapeutics PLC
LSE:AREC

Watchlist Manager
Arecor Therapeutics PLC
LSE:AREC
Watchlist
Price: 157.06 GBX -0.91%
Updated: May 27, 2024

Arecor Therapeutics PLC
Selling, General & Administrative

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Arecor Therapeutics PLC
Selling, General & Administrative Peer Comparison

Comparables:
CNTA
AUTL
BCYC
IMCR
GNS

Competitive Selling, General & Administrative Analysis
Latest Figures & CAGR of Competitors

Company Selling, General & Administrative CAGR 3Y CAGR 5Y CAGR 10Y
A
Arecor Therapeutics PLC
LSE:AREC
Selling, General & Administrative
-£5m
CAGR 3-Years
-81%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Centessa Pharmaceuticals PLC
NASDAQ:CNTA
Selling, General & Administrative
-$53.7m
CAGR 3-Years
-261%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Autolus Therapeutics PLC
NASDAQ:AUTL
Selling, General & Administrative
-$54.9m
CAGR 3-Years
-10%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Bicycle Therapeutics PLC
NASDAQ:BCYC
Selling, General & Administrative
-$62.3m
CAGR 3-Years
-24%
CAGR 5-Years
-46%
CAGR 10-Years
N/A
Immunocore Holdings PLC
NASDAQ:IMCR
Selling, General & Administrative
-£144.5m
CAGR 3-Years
-47%
CAGR 5-Years
-38%
CAGR 10-Years
N/A
Genus PLC
LSE:GNS
Selling, General & Administrative
-£7.6m
CAGR 3-Years
-1%
CAGR 5-Years
-10%
CAGR 10-Years
-9%

See Also

What is Arecor Therapeutics PLC's Selling, General & Administrative?
Selling, General & Administrative
-5m GBP

Based on the financial report for Dec 31, 2022, Arecor Therapeutics PLC's Selling, General & Administrative amounts to -5m GBP.

What is Arecor Therapeutics PLC's Selling, General & Administrative growth rate?
Selling, General & Administrative CAGR 3Y
-81%

Over the last year, the Selling, General & Administrative growth was -127%. The average annual Selling, General & Administrative growth rates for Arecor Therapeutics PLC have been -81% over the past three years .